SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015986
Filing Date
2021-11-15
Accepted
2021-11-15 16:18:04
Documents
103
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ibio-20210930x10q.htm   iXBRL 10-Q 1958934
2 EX-31.1 ibio-20210930xex31d1.htm EX-31.1 18035
3 EX-31.2 ibio-20210930xex31d2.htm EX-31.2 17857
4 EX-32.1 ibio-20210930xex32d1.htm EX-32.1 7618
5 EX-32.2 ibio-20210930xex32d2.htm EX-32.2 6580
  Complete submission text file 0001558370-21-015986.txt   9738943

Data Files

Seq Description Document Type Size
6 EX-101.SCH ibio-20210930.xsd EX-101.SCH 93263
7 EX-101.CAL ibio-20210930_cal.xml EX-101.CAL 103824
8 EX-101.DEF ibio-20210930_def.xml EX-101.DEF 244768
9 EX-101.LAB ibio-20210930_lab.xml EX-101.LAB 580260
10 EX-101.PRE ibio-20210930_pre.xml EX-101.PRE 518341
11 EXTRACTED XBRL INSTANCE DOCUMENT ibio-20210930x10q_htm.xml XML 1876885
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35023 | Film No.: 211410915
SIC: 2834 Pharmaceutical Preparations